Induction Healthcare Group PLC - London-based digital health platform - Says Chief Executive Officer James Balmain is stepping down with immediate effect. Balmain will take on a new advisory role where he will directly ‘support the evolution and execution of group product strategy, together with national and regional sales’.
Says Non-Executive Chair Christopher Samler will assume the interim role of executive chair, providing day to day leadership of the business pending the recruitment of a new permanent CEO.
Balmain says: ‘I’m looking forward to spending much more of my time on product strategy and sales, whilst also supporting the business as it navigates an important transitional period.’
Current stock price: 20.40 pence, down 9.3%
12-month change: down 65%
Copyright 2023 Alliance News Ltd. All Rights Reserved.
